Treatment Options and Course of Action in Relapsed Multiple Myeloma
In this interview we discuss how relapse in multiple myeloma manifests and treatment options for relapsed/refractory patients.
Homologous Recombination Deficiency and PARP Inhibition in Ovarian Cancer
As part of our coverage of the 2017 ASCO Annual Meeting, we discuss homologous recombination deficiency in ovarian cancer and PARP inhibitors.
TKI Discontinuation Possible for Some CML Patients
Ahead of the 2017 ASCO Annual Meeting, we discuss the discontinuation of TKIs in some chronic myeloid leukemia patients.
Addressing Physical, Cognitive Effects of ADT in Prostate Cancer Patients
In this interview ahead of ASCO 2017 we discuss the physical and cognitive effects of androgen deprivation therapy in older men treated for prostate cancer.
Older Age Itself Rarely a Restriction to Treatment of Lung Cancer
Ahead of the 2017 ASCO Annual Meeting, we discuss how to approach treatment for older patients with lung cancer.
With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way
In this interview we discuss important developments in the diagnosis and management of breast cancer and more.
Influence of Aerobic Exercise on QOL During Prostate Cancer Treatment
In this interview we discuss a study that looked at the effect of an 8-week exercise intervention on treatment side effects for patients with prostate cancer.
Treating Triple-Negative Breast Cancer
This slide deck covers the treatment of triple-negative breast cancer, a heterogeneous disease made up of numerous subtypes, and includes clinical variables that can help with prognosis and guide in treatment choice.
By clicking Accept, you agree to become a member of the UBM Medica Community.